Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ala-Eddine Deghmane & Muhamed-Kheir Taha. (2022) Product review on the IMD serogroup B vaccine Bexsero®. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Peter T. Beernink. (2020) Effect of complement Factor H on antibody repertoire and protection elicited by meningococcal capsular group B vaccines containing Factor H binding protein. Human Vaccines & Immunotherapeutics 16:3, pages 703-712.
Read now
Read now
Susanna Esposito, Sonia Bianchini, Claudia Tagliabue, Giulia Umbrello, Barbara Madini, Giada Di Pietro & Nicola Principi. (2018) Impact of a website based educational program for increasing vaccination coverage among adolescents. Human Vaccines & Immunotherapeutics 14:4, pages 961-968.
Read now
Read now
Yordanka Masforrol, Jeovanis Gil, Darien García, Jesús Noda, Yassel Ramos, Lázaro Betancourt, Osmany Guirola, Sonia González, Boris Acevedo, Vladimir Besada, Osvaldo Reyes & Luis Javier González. (2017) A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C. Human Vaccines & Immunotherapeutics 13:11, pages 2548-2560.
Read now
Read now
Giulia Piccini, Alessandro Torelli, Elena Gianchecchi, Simona Piccirella & Emanuele Montomoli. (2016) Fighting Neisseria meningitidis: past and current vaccination strategies. Expert Review of Vaccines 15:11, pages 1393-1407.
Read now
Read now
Nathan James Brendish & Robert Charles Read. (2015) Neisseria meningitidis serogroup B bivalent factor H binding protein vaccine. Expert Review of Vaccines 14:4, pages 493-503.
Read now
Read now
Articles from other publishers (11)
Himadri B. Thapa, Anna M. Müller, Andrew Camilli & Stefan Schild. (2021) An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2. Frontiers in Microbiology 12.
Crossref
Crossref
Irum Syed & R. Mark Wooten. (2021) Interactions Between Pathogenic Burkholderia and the Complement System: A Review of Potential Immune Evasion Mechanisms. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Hayoung Lee, Sung Ho Yun, Ju-yong Hyon, Sang-Yeop Lee, Yoon-Sun Yi, Chi-Won Choi, Sangmi Jun, Edmond Changkyun Park & Seung Il Kim. (2021) Streptococcus equi-derived extracellular vesicles as a vaccine candidate against Streptococcus equi infection. Veterinary Microbiology 259, pages 109165.
Crossref
Crossref
Peter T. Beernink, Vianca Vianzon, Lisa A. Lewis, Gregory R. Moe & Dan M. Granoff. (2019) A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine. mBio 10:3.
Crossref
Crossref
M.B. van Ravenhorst, M.W. Bijlsma, M.A. van Houten, V.M.D. Struben, A.S. Anderson, J. Eiden, L. Hao, K.U. Jansen, H. Jones, N. Kitchin, L. Pedneault, E.A.M. Sanders & A. van der Ende. (2017) Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort study. Clinical Microbiology and Infection 23:8, pages 573.e1-573.e7.
Crossref
Crossref
Aimee Tan, John M. Atack, Michael P. Jennings & Kate L. Seib. (2016) The Capricious Nature of Bacterial Pathogens: Phasevarions and Vaccine Development. Frontiers in Immunology 7.
Crossref
Crossref
Nicole E Basta & Hannah Christensen. (2016) 4CMenB vaccine effectiveness: reasons for optimism. The Lancet 388:10061, pages 2719-2721.
Crossref
Crossref
Patrick L. Ahl, Christopher Mensch, Binghua Hu, Heidi Pixley, Lan Zhang, Lance Dieter, Ryann Russell, William J. Smith, Craig Przysiecki, Mike Kosinski & Jeffrey T. Blue. (2016) Accelerating Vaccine Formulation Development Using Design of Experiment Stability Studies. Journal of Pharmaceutical Sciences 105:10, pages 3046-3056.
Crossref
Crossref
Lan Zhang, Zhiyun Wen, Jing Lin, Hui Xu, Paul Herbert, Xin-Min Wang, John T. Mehl, Patrick L. Ahl, Lance Dieter, Ryann Russell, Mike J. Kosinski & Craig T. Przysiecki. (2016) Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification. Vaccine 34:35, pages 4250-4256.
Crossref
Crossref
Shruti Sridhar, Brian Greenwood, Christopher Head, Stanley A Plotkin, Marco A Sáfadi, Samir Saha, Muhamed-Kheir Taha, Oyewale Tomori & Bradford D Gessner. (2015) Global incidence of serogroup B invasive meningococcal disease: a systematic review. The Lancet Infectious Diseases 15:11, pages 1334-1346.
Crossref
Crossref
L. Salleras. (2015) Seguridad de la vacuna 4CMenB frente a la enfermedad meningocócica producida por el serogrupo B. Vacunas 16:1, pages 1-5.
Crossref
Crossref